Development of a Mass Spectrometry-Based Method for Quantification of Ustekinumab in Serum Specimens
Conclusions:
The newly developed LC/MS-based method was shown to be feasible for UST quantification. This analytical approach may lead to individualized dosing and improved patient care.
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Original Article Source Type: research
More News: Crohn's Disease | Drugs & Pharmacology | Inflammatory Bowel Disease | Laboratory Medicine | Stelara | Study